Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
3.905
-0.305 (-7.24%)
Mar 31, 2025, 1:31 PM EDT - Market open
Design Therapeutics Employees
Design Therapeutics had 54 employees as of December 31, 2024. The number of employees decreased by 4 or -6.90% compared to the previous year.
Employees
54
Change (1Y)
-4
Growth (1Y)
-6.90%
Revenue / Employee
n/a
Profits / Employee
-$918,296
Market Cap
221.66M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 54 | -4 | -6.90% |
Dec 31, 2023 | 58 | 0 | - |
Dec 31, 2022 | 58 | 20 | 52.63% |
Dec 31, 2021 | 38 | 23 | 153.33% |
Dec 31, 2020 | 15 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DSGN News
- 21 days ago - Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Design Therapeutics to Participate in Leerink's Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Design Therapeutics to Participate in Multiple Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio - GlobeNewsWire
- 8 months ago - Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio - GlobeNewsWire
- 11 months ago - Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones - GlobeNewsWire
- 11 months ago - Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 1 year ago - Design Therapeutics, Inc. (DSGN) Q4 2023 Earnings Call Transcript - Seeking Alpha